The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04538664
Brief Title: A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions (PAPILLON)

First Submitted : August 31, 2020
First Submitted that Met QC Criteria : August 31, 2020
First Posted : September 4, 2020

Results First Submitted : May 1, 2024
Results First Submitted that Met QC Criteria : May 1, 2024
Results First Posted : May 29, 2024

Last Update Submitted that Met QC Criteria : June 18, 2024
Last Update Posted : June 20, 2024